Table of Contents
International Journal of Molecular Imaging
Volume 2011, Article ID 195037, 9 pages
http://dx.doi.org/10.1155/2011/195037
Research Article

The Role of CT-Based Attenuation Correction and Collimator Blurring Correction in Striatal Spect Quantification

1Nuclear Medicine, Faculty of Health Sciences, Stellenbosch University and Tygerberg Hospital, Tygerberg, 7505, Cape Town, South Africa
2MRC Unit for Stress and Anxiety Disorders, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa
3Laboratory for Cognitive Neurology and Medical Imaging Research Center, KU 3000 Leuven, Belgium

Received 30 July 2010; Revised 12 January 2011; Accepted 13 February 2011

Academic Editor: Georges El Fakhri

Copyright © 2011 J. M. Warwick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zaidi and G. El Fakhri, “Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 7, pp. 1330–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. B. M. W. Tsui, E. C. Frey, X. Zhao, D. S. Lalush, R. E. Johnston, and W. H. McCartney, “The importance and implementation of accurate 3D compensation methods for quantitative SPECT,” Physics in Medicine and Biology, vol. 39, no. 3, article no. 015, pp. 509–530, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Soret, P. M. Koulibaly, J. Darcourt, S. Hapdey, and I. Buvat, “Quantitative accuracy of dopaminergic neurotransmission imaging with 123I SPECT,” Journal of Nuclear Medicine, vol. 44, no. 7, pp. 1184–1193, 2003. View at Google Scholar · View at Scopus
  4. L. K. Leong, M. K. O'Connor, and D. M. Maraganore, “Quantitation of iodine-123-β-CIT dopamine receptor uptake in a phantom model,” Journal of Nuclear Medicine Technology, vol. 27, no. 2, pp. 117–122, 1999. View at Google Scholar · View at Scopus
  5. J. Hashimoto, T. Sasaki, K. Ogawa et al., “Effects of scatter and attenuation correction on quantitative analysis of β-CIT brain SPET,” Nuclear Medicine Communications, vol. 20, no. 2, pp. 159–165, 1999. View at Google Scholar
  6. D. Pareto, A. Cot, J. Pavía et al., “Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 10, pp. 1322–1329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Cot, C. Falcón, C. Crespo et al., “Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction,” Journal of Nuclear Medicine, vol. 46, no. 9, pp. 1497–1504, 2005. View at Google Scholar · View at Scopus
  8. S. Ghoorun, K. Baete, J. Nuyts, W. Groenewald, and P. Dupont, “The influence of attenuation correction and reconstruction techniques on the detection of hypo-perfused lesions in brain SPECT images,” Nuclear Medicine Communications, vol. 27, no. 10, pp. 765–772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Zaknun, H. Schücktanz, and F. Aichner, “Impact of instrumentation on DaTSCAN imaging: how feasible is the concept of cross-systems correction factor?” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 2, pp. 194–203, 2007. View at Google Scholar · View at Scopus
  10. K. Van Laere, M. Koole, J. Versijpt, and R. Dierckx, “Non-uniform versus uniform attenuation correction in brain perfusion SPET of healthy volunteers,” European Journal of Nuclear Medicine, vol. 28, no. 1, pp. 90–98, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Rajeevan, I. G. Zubal, S. Q. Ramsby, S. S. Zoghbi, J. Seibyl, and R. B. Innis, “Significance of nonuniform attenuation correction in quantitative brain SPECT imaging,” Journal of Nuclear Medicine, vol. 39, no. 10, pp. 1719–1726, 1998. View at Google Scholar · View at Scopus
  12. R. Z. Stodilka, B. J. Kemp, F. S. Prato, and R. L. Nicholson, “Importance of bone attenuation in brain SPECT quantification,” Journal of Nuclear Medicine, vol. 39, no. 1, pp. 190–197, 1998. View at Google Scholar · View at Scopus
  13. L. T. Chang, “A method for attenuation correction in radionuclide computed tomography,” IEEE Transactions on Nuclear Science, vol. 25, no. 1, pp. 638–643, 1977. View at Google Scholar · View at Scopus
  14. W. Koch, P. E. Radau, W. Münzing, and K. Tatsch, “Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 4, pp. 495–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Crespo, J. Gallego, A. Cot et al., “Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 7, pp. 1334–1342, 2008. View at Publisher · View at Google Scholar
  16. A. M. Catafau, S. Bullich, M. Danús et al., “Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms,” Synapse, vol. 62, no. 1, pp. 62–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bullich, A. Cot, J. Gallego et al., “Impact of scatter correction on D2 receptor occupancy measurements using 123I-IBZM SPECT: comparison to C-Raclopride PET,” NeuroImage, vol. 50, no. 4, pp. 1511–1518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. F. J. Beekman, H. W. A. M. De Jong, and S. Van Geloven, “Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation,” IEEE Transactions on Medical Imaging, vol. 21, no. 8, pp. 867–877, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Du, B. M. W. Tsui, and E. C. Frey, “Model-based compensation for quantitative 123I brain SPECT imaging,” Physics in Medicine and Biology, vol. 51, no. 5, pp. 1269–1282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. T. Kuikka, “Quantitative accuracy of serotonergic neurotransmission imaging with high-resolution 123I SPECT,” NuklearMedizin, vol. 43, no. 6, pp. 185–189, 2004. View at Google Scholar · View at Scopus
  21. J. Darcourt, J. Booij, K. Tatsch et al., “EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 443–450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. M. Hudson and R. S. Larkin, “Accelerated image reconstruction using ordered subsets of projection data,” IEEE Transactions on Medical Imaging, vol. 13, no. 4, pp. 601–609, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. Dickson, L. Tossici-Bolt, T. Sera et al., “The impact of reconstruction method on the quantification of DaTSCAN images,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 1, pp. 23–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Gokan, Y. Ohgiya, H. Munechika, H. Nobusawa, and M. Hirose, “Renal cyst pseudoenhancement with beam hardening effect on CT attenuation,” Radiation Medicine, vol. 20, no. 4, pp. 187–190, 2002. View at Google Scholar · View at Scopus
  25. K. Tatsch, S. Asenbaum, P. Bartenstein, A. Catafau, C. Halldin, and L. S. Pilowsky, “European association of nuclear medicine procedure guidelines for brain neurotransmission SPET using 123I-labelled dopamine transporter ligands,” European Journal of Nuclear Medicine, vol. 29, no. 10, pp. BP30–BP35, 2002. View at Google Scholar
  26. C. Rorden and M. Brett, “Stereotaxic display of brain lesions,” Behavioural Neurology, vol. 12, no. 4, pp. 191–200, 2000. View at Google Scholar · View at Scopus
  27. M. B. First, R. L. Spitzer, M. Gibbon, and J. B. W. Williams, Structured Clinical Interview for DSM-IV Axis I Disorders, Biometrics Research Department, New York State Research Institute, New York, NY, USA, Clinician edition, 1996.
  28. P. E. Radau, R. Linke, P. J. Slomka, and K. Tatsch, “Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism,” Journal of Nuclear Medicine, vol. 41, no. 2, pp. 220–227, 2000. View at Google Scholar · View at Scopus
  29. R. J. Morton, M. J. Guy, C. A. Marshall, E. A. Clarke, and P. J. Hinton, “Variation of DaTSCAN quantification between different gamma camera types,” Nuclear Medicine Communications, vol. 26, no. 12, pp. 1131–1137, 2005. View at Publisher · View at Google Scholar · View at Scopus